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NANKIVELL Et AL. diagnostic threshold within the current version to a "foci of tubulitis (Banff t1, t2, or t3) with minor interstitial infiltration (score of i0 or i1); or interstitial infiltration (i2, i3) with mild (t1) tubulitis"; while excluding intimal arteritis. 8 The borderline category now contains eight permutations of inflammation and tubulitis scores: i0t1; i0t2; i0t3; i1t1; i1t2; i1t3; i2t1; and i3t1. Furthermore, interstitial inflammation without tubulitis (Banff i1t0, i2t0, and i3t0) is questionably excluded. The expanded borderline TCMR category includes tubulitis without interstitial inflammation (<10%, Banff i0), termed "isolated tubulitis" (ISO-T).
Inclusion of ISO-T into the borderline TCMR category is controversial. A worldwide, web-based survey by Becker et al, recently reported that 67% of experienced transplant nephropathologists still used the original Banff 1997 definition of borderline rejection (requiring i1), as did most of the influential authors of published literature. 9 The t1i0 (or ISO-T) category was specifically criticized, and an urgent evidence-based clarification of the lower thresholds for borderline TCMR was requested to improve its clinical utility.
The purpose of this single-center observational study was evaluation of the clinical and histological significance of ISO-T, and to determine whether this entity constitutes borderline TCMR.
| MATERIAL S AND ME THODS

| Study hypotheses and specific aims
Our central question was whether tubulitis in the absence of interstitial inflammation (ISO-T) represents borderline TCMR. The specific study aims were to:
Prevalence rates for ISO-T, Banff tubulitis and inflammation
categories, from indication and surveillance biopsies.
Correlate tubulitis with interstitial inflammation and markers of
antibody-mediated rejection by histology; renal dysfunction; immunosuppression; and clinical risk factors including ischemic delayed graft function, BKVAN, or previously treated TCMR.
Evaluate outcomes of ISO-T, including immediate renal function,
anti-rejection therapy use, and subsequent rejection episodes or graft loss.
Formulate recommendations pertaining the relevant diagnostic
threshold of Banff borderline TCMR.
| Study population and histological evaluation
Consecutive, indication-and surveillance-kidney biopsy specimens Histology was contemporaneously reported by specialized nephropathologists (n = 6), scored by the Banff schema, and routinely tested for SV40T (Cell Marque, clone MRQ-4, Rocklin, CA) and C4d
(rabbit polyclonal anti-C4d antibody, Cell Marque) by immunohistochemistry. A single, blinded pathologist (CPNG) then retrospectively reevaluated selected ISO-T indication samples to address the questions of: etiological diagnoses; precise quantification of infiltrating cells (to 1% of cortex rather than broad category estimation) and tubulitis grading (using Banff 1997 criteria) within scarred and unscarred cortex; and total inflammation (our modified Banff ti definition excluded subcapsular cortex, differing from the original which was specifically optimized for correlation with T cell transcripts). 10 Tubulitis was preferentially evaluated in slides stained by periodic acid-Schiff.
| Study design and principal histological categories
Five mutually exclusive categories were formed a priori, based solely on extent of tubulitis and inflammation (Banff t and i scores, respectively). Microvascular and arterial vessel inflammation, C4d and SV40T data were not used for classification.
These specific diagnostic categories were:
1. Isolated tubulitis (ISO-T); where foci of tubulitis (Banff scores t1, t2, or t3) were present without significant interstitial inflammation of non-scarred cortex (Banff i0). ISO-T was the principal category of interest.
Inflammation and tubulitis (NIL); defined as Banff t0i0 and was
used as the negative comparator group.
3.
Mild "borderline" tubulitis and inflammation (BL-T); corresponding to borderline TCMR intensity scores (Banff i1t1, i2t1, i3t1, i1t2, and i1t3) accompanied interstitial infiltration), formed the positive comparator group,
4.
Biopsies with marked inflammation and tubulitis (TUB-I, corresponding to Banff 1A TCMR or worse; Banff i and t ≥ 2, n = 91);
and ill-defined solitary inflammation (t0 with i1, i2, or i3, n = 29, not conventionally considered as TCMR because of absent tubulitis), were separately evaluated.
| Statistical analysis
The research design was a retrospective, single-center, cohort study. . PCA compared ISO-T against "TCMR" (both BL-T and TUB-I groups) and NIL/normal pathology samples to delineate correct categorization. Data are expressed as mean ± SD, unless otherwise stated. All P values were two-sided, and a probability below 0.05 was considered significant.
| RE SULTS
| Study cohort demographic data
From 2088 consecutive biopsies screened, 33 were excluded because of inadequate tissue (detailed Table S2 ), leaving 2055 samples containing sufficient tubular tissue. These included samples were used to estimate the prevalence of ISO-T; effect of sample size on recognition of tubulitis; and to generate the three primary study subcategories (NIL, ISO-T, and BL-T), and two other categories (TUB-I and the excluded solitary inflammation group).
Study recipients (n = 775) were 46.7 ± 12.9 years old, 61.0%
male, and received a kidney with an HLA mismatch of 3.8 ± 1.7, from a deceased donor in 76% (full data, 
| Renal transplant histopathology
Summary pathology results from all protocol (n = 1467) and indication (n = 588) histology (n = 2055) from 775 transplant recipients are detailed ( Figures 1 and 2 , Table S4 ). (Table S5 ). The univariable histological predictors of tubulitis included: Banff acute i, v, g, and ptc scores (all P < .001); chronic ci, ct (both P < .001) and cg (P = .02); and C4d scores (P < .001), reflecting cellular and antibody alloimmune activity. SV40T immunohistochemistry and acute tubular necrosis (ATN) both predicted tubulitis (P < .001). The probability of observing tubulitis weakly associated with surrogate markers of biopsy size, including the number of glomeruli (P = .01), maximal core length (P = .004), number of cores (P < .001), and presence of medulla (P = .006).
By multivariable logistic regression, independent clinical predictors for tubulitis were HLA mismatch (P = .007), prior early TCMR (P < .001) and antibody-mediated rejection (P = .006), pulse corticosteroid use, and BKVAN (both P < .001, Table 1 ). The multivariable histological predictors of tubulitis included Banff scores for inflammation (OR 14.697, 95% 10.138-21.307, P < .001), peritubular capillaritis (P < 0.001), tubular atrophy (P < .001) and BK infection (P = .005, Table 1 ).
These results were confirmed by multivariable binomial GEE (for repeated sampling) of 772 patients. The histological predictors of tubulitis included Banff i (P < .001), ptc (P = .002), and ct scores
The prevalence of tubulitis and inflammation by category. The 2 × 2 prevalence matrices of inflammation and tubulitis are illustrated by scoring categories (n = 2033, with large numbers of i0t0 biopsies were omitted for clarity, and t0 inflammation excluded Tubulitis was strongly predicted by interstitial inflammation (Banff i), peritubular capillary inflammation (ptc, the site of cellular egress into the interstitial space), tubular atrophy (Banff ct) and BK virus allograft infection. DSA, donor specific antibodies (any DSA, MFI > 500); MFI, median fluorescence intensity; BKVAN, BK viral allograft nephropathy; SV40T, simian virus 40 large T antigen; OR, odds ratio; CI, confidence interval C4d, complement degradation split-product 4d.
(P < .001), and SV40T positivity (P < .001, Table 2 ). Predictive clinical factors of tubulitis included biopsy time posttransplant (P < .001), indication biopsy (P < .001), combined kidney-pancreas transplant (P = .014, vs kidney alone), tacrolimus therapy (P = .006, vs cyclosporine), and prior BKVAN (P = .002), or pulse corticosteroid therapy (P < .001), and HLA mismatch P = .024, Table 1 ). Further validation by multinomial ordinal logistic regression found explanatory histological variables of tubulitis were Banff i (P < .001), ci (P < .001), ptc (P < .001) and SV40T scores (P = .003, Table S6 for full data).
| The effect of sample size on tubulitis scoring
Because tubulitis occurs in a patchy distribution, we questioned whether sampling error from small biopsy cores was responsible for the ISO-T pattern. Figure 3 , all biopsies), compared to larger cores (>5 glomeruli, χ 2 = 5.982, P = .014). The adjusted odd ratio for tubulitis fell significantly when the biopsy contained fewer than 5 glomeruli (Figure 3 ).
| Initial group selection and validation by discriminant analysis
The overall prevalence of ISO-T was 19.1% (393/2055), and simi- SV40T. Reclassifications were only from BL-T to TUB-I (n = 6). ISO-T and NIL categories were unchanged. Hence, classification assigned by inflammation and tubulitis appeared biologically reasonable, reflecting the natural combinations of intrinsic pathology.
| Clinical and pathological diagnoses associated with isolated tubulitis
The dominant pathological diagnoses of all included study biopsies overall), and 5/286 of ISO-T samples (Table S9 ).
| ISO-T indication-biopsies and immediate outcomes
The clinical significance of ISO-T was evaluated in biopsies indicated by graft dysfunction (n = 107, Table 4 i-Banff% (r = .490, P < .001), i-IFTA% (r = .632, P < .001), and i-IFTA scores (rho = 0.583, P < .001, Figure 6 ). Hence, tubulitis and inflammation correlated in both scarred and non-scarred cortex.
| Histological and functional outcomes
Repeated biopsy sampling assessed histological outcomes. Biopsy pairs of sequential histological samples were stratified by the category of the first biopsy (n = 1197 for three categories), and assessed for changes in function and structure (Table 5 ). Category classification changed in 56% (670 of 1197) on the next biopsy-pair. Tubulitis scores in ISO-T improved (Banff t score 1.03 ± 0.17 to 0.54 ± 0.66, P < .001), but still displayed some inflammation and fibrosis, and reduced function in ISO-T and BL-T groups (compared with NIL, Figure 4 ) at initial and repeat biopsy times (additional data Table S10 ). Summary categories sorted by inflammation and tubulitis scores of selected biopsies (n = 1935, including protocol samples). NIL is Banff zero i and t scores; ISO-T is isolated tubulitis, and BL-T is borderline tubulitis with inflammation. Biopsies with severe inflammation with tubulitis (Banff i2/t2 or greater, n = 91) and inflammation without tubulitis of uncertain categorization (n = 29) were excluded. Key: a, P < .05; b, <.01; c, <.001 vs NIL; and ISO-T vs. BL-T are x, P < .05; y, <.01; z < .001, by multiple comparison testing (additional data in Table S7 ).
TA B L E 3 Histopathological and clinical data by study group
C4d, complement degradation split-product 4d; BKVAN, BK viral allograft nephropathy; SV40T, simian virus 40 large T antigen; IF/TA, interstitial fibrosis and tubular atrophy; CAMR, chronic antibody mediated rejection; TCMR, T cell mediated rejection; CNI, calcineurin inhibitor; DSA, donor specific antibody; MFI, median fluorescence intensity.
BL-T cases received more pulse corticosteroid, responded with amelioration of inflammation over time (delta i score -0.76 ± 0.88, P < .001).
The functional and structural outcomes of ISO-T, broadly fell between NIL and the two "acute" TCMR subcategories (BL-T and TUB-I, Figure 4 ).
The death-censored graft survival of ISO-T closely paralleled NIL, and also separated cleanly from BL-T and TUB-I (all samples with matched data, n = 1644, Figure 7 ). The respective 1-and 5-year graft survivals for NIL and ISO-T comparable at 98.1% and 91.7%, and 98.8% and 92.7%, versus 94.5% and 81.7% for BL-T (P < .001 vs.
NIL and ISO-T).
| D ISCUSS I ON
Tubulitis is a major diagnostic criterion used by the Banff schema for Table S5 ).
*Two cases recoded from IF/TA (n = 30, 28.0%) to chronic TCMR (n = 3, 2.8%).
TA B L E 4
The dominant pathological diagnosis from inflammation/tubulitis categories from the subset of indication biopsies (n = 482) and laminin staining) is associated with areas of active tubulitis in TCMR. 21 Tubulitis in late rejection accompanies severe inflammation across multiple compartments, is a single aspect of uncontrolled alloimmune destruction.
23,24
Our results indicate a third mechanistic pathway causing tubulitis:
where an initial tubular injury is followed by a secondary response. Tubular inflammation has been observed in renal ischemia 25 ; experimental nephotoxicity from aristolochic acid, 26 gentamicin, 27 and Adriamycin nephropathy. 28 Nonalloimmune tubulitis can also result from bacterial and viral allograft infection, 29, 30 medication-induced nephritis, 31 and following adoptive immunotherapy. 32 Experienced pathologists routinely disregard tubulitis within severely atrophic tubules as a nonspecific response to damage. 
